Advertisement

Topics

Vernalis PLC: FDA Issues Complete Response Letter on CCP-08 NDA

02:08 EDT 7 Aug 2017 | BioMedReports - Blog

WINNERSH, UNITED KINGDOM--(Marketwired - Aug 7, 2017) - Vernalis PLC ( LSE : VER)

07 August 2017

LSE: VER

FDA Issues a Complete Response

Read more...

Original Article: Vernalis PLC: FDA Issues Complete Response Letter on CCP-08 NDA

NEXT ARTICLE

More From BioPortfolio on "Vernalis PLC: FDA Issues Complete Response Letter on CCP-08 NDA"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...